Abstract
The role of Artificial Intelligence (AI) in clinical decision-making raises issues of trust. One issue concerns the conditions of trusting the AI which tends to be based on validation. However, little attention has been given to how validation is formed, how comparisons come to be accepted, and how AI algorithms are trusted in decision-making. Drawing on interviews with collaborative researchers developing three AI technologies for the early diagnosis of pulmonary hypertension (PH), we show how validation of the AI is jointly produced so that trust in the algorithm is built up through the negotiation of criteria and terms of comparison during interactions. These processes build up interpretability and interrogation, and co-constitute trust in the technology. As they do so, it becomes difficult to sustain a strict distinction between artificial and human/social intelligence.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.